CollPlant Biotechnologies Ltd. CLGN
4.01 USD -0.13 -3.02%
As of Nov 2, 11:27 AM ET
- YTD
- -71.36%
- 1 year
- -81.44%
- Open
- 4.15
- Prev close
- 4.14
- Mkt cap
- 11.55M
- Vol
- 20.81K
- Avg vol
- 366.36K
- EPS
- -9.33
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.95
- High
- 4.20
- Forward P/E
- -8.82
- Beta
- 0.48
- Short ratio
- 0.70
- Inst. own
- 12.23%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 20, 2024
- 50-d avg
- 4.04
- 200-d avg
- 4.90
- 1y target
- 12.50
MAX chart
Chart tools
Chart is warming up
The all-time price history for CLGN has not been loaded yet. Try again in a moment.
Altman Z-Score
-29.70 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 4
P/E -1.5×
P/S 7.2×
P/B 2.8×
P/FCF -1.8×
EV/EBITDA -1.3×
EV/Sales 5.9×
FCF Yield -55.3%
Gross Margin 26.3%
Operating Margin -484.3%
Net Margin -484.6%
ROE -188.9%
ROIC -128.6%
ROA -106.5%
Revenue 360.4%
Operating Income 33.4%
EPS (diluted) 35.2%
Free Cash Flow 35.2%
Current Ratio 2.5×
Quick Ratio 2.3×
Debt / Equity 0.5×
Net Debt / EBITDA 0.3×
Interest Coverage -766×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31